“Severe Hyponatremia With Normokalemia in Pembrolizumab-Lenvatinib Combination Therapy for Metastatic Renal Cell Carcinoma: A Case of Suspected Secondary Adrenal Insufficiency and Clinical Differentials”. Open Access Indonesian Journal of Medical Reviews, vol. 6, no. 1, Nov. 2025, pp. 35-50, https://doi.org/10.37275/oaijmr.v6i1.826.